The Need for High-Purity A9 Dopaminergic Neurons within Parkinson’s Disease Models
12:20 pm - Wednesday 4th February 2026
- Understand the biological significance of A9 vs. A10 dopaminergic neuron subtypes in Parkinson’s disease
- Learn how HD-DoE technology enables targeted development of A9 neurons with desired phenotypic profiles
- Review of key phenotypic and functional QC benchmarks
- Discussion of recommended use cases and applications in discovery and disease modeling
